ATM Inhibition Boosted Pig Genome Editing
Researchers successfully increased targeted gene insertion rates in pig zygotes using ATM inhibition.
Updated on Sept. 23, 2026 in Biotech
Scientists have improved genome editing in pig zygotes by applying transient inhibition of ataxia-telangiectasia mutated during the AAV transduction process. This approach significantly boosted the efficiency of inserting DNA fragments without harming embryo quality.
Why it matters
Direct genome editing of zygotes is notoriously difficult for long-fragment insertions, limiting progress in livestock research. This breakthrough provides a more reliable method to generate complex, multi-gene edits in porcine models.
ATM inhibition increased single knock-in efficiency to 66% and double knock-in efficiency to 52%, compared to baseline rates of 33% and 19% respectively. These improvements did not compromise overall blastocyst formation or quality.
The details
The research utilized adeno-associated virus (AAV) donors to facilitate targeted integration in pig zygotes. By applying transient ATM inhibition, the team successfully produced F0 fetuses where a significant portion of cells were edited, yielding a 33% success rate post-transfer.
Timeline
September 23, 2026: The research results were published online.
The Big Picture
This study follows a pattern set by the development of CRISPR-Cas9 genome editing by optimizing the cellular mechanisms required to ensure precise and efficient DNA modification.
This development could accelerate the creation of advanced animal models for medical research, potentially speeding up the discovery of human disease treatments. It also offers potential for more precise agricultural breeding programs to improve livestock traits.
The takeaway
Targeting cellular repair pathways like ATM can significantly overcome barriers in complex genetic engineering. These methods may soon be applied to other large animal species to increase the speed and accuracy of agricultural and biomedical research.
Further reading
Explore more breakthroughs in Biotech.
Source note: This article includes information reported by Nature.
